This document discusses endometriosis, defining it as the presence of endometrial tissue outside the uterus. It affects 7-10% of women. There are three main theories for its pathogenesis: retrograde menstruation, lymphatic/vascular dissemination, and coelomic metaplasia. Symptoms include dysmenorrhea, deep dyspareunia, and chronic pelvic pain. Endometriosis is most commonly found on the ovaries and other pelvic structures. Diagnosis requires laparoscopy and biopsy. Treatment options include medical therapy using hormones or NSAIDs as well as extirpative surgery to remove lesions.
Presentation1.pptx, radiological imaging of endometriosis.Abdellah Nazeer
Radiological imaging of endometriosis and adenomyosis.
Endometriosis and adenomyosis are common gynecological conditions that can be difficult to diagnose without imaging. MRI is the preferred imaging modality for evaluating these conditions. [1] Adenomyosis is characterized by ectopic endometrial glands within the myometrium, seen on MRI as junctional zone thickening over 12mm or ill-defined high T2 signal regions. [2] Endometriosis appears as powder-burn lesions, ovarian endometriomas or deep infiltrating nodules. Radiologists use MRI features like junctional zone measurements and high T1/T2 signals to diagnose and characterize
Transvaginal ultrasound and MRI are used to diagnose adenomyosis. On transvaginal ultrasound, the uterus may appear globally enlarged with heterogeneous myometrial texture and poorly defined endometrial-myometrial junction. MRI can identify adenomyosis as increased junctional zone thickness over 12mm with T2 hyperintense foci. Hysteroscopy with biopsy can confirm the diagnosis but is rarely used. Treatment options include NSAIDs, hormonal therapy like combined oral contraceptives or progestogens to reduce bleeding and pain, and long-acting reversible contraceptives like the levonorgestrel IUS.
Endometriosis is a condition where endometrial tissue grows outside the uterine cavity, most commonly on the ovaries and pelvic peritoneum. It causes pelvic pain and infertility and is diagnosed through laparoscopy. Treatment involves medical therapy using hormones to suppress menstruation, surgical excision or ablation of lesions, or a combination. Symptoms range from mild to severe depending on location and extent of disease.
Gynaecology Thicknend Endometrium leceture 3 part 2.pptxRadiantree
Endometrial cancer is the most common gynecological cancer in the general population. It typically affects postmenopausal women around age 65. Obesity, diabetes, hormone therapy, and tamoxifen use can increase risk. Patients often present with abnormal uterine bleeding. Ultrasound is used initially, with endometrial thickness under 5mm having a low risk of cancer. Sonohysterography may be used if the etiology of thickening remains unclear after biopsy or ultrasound. Features of cancer on ultrasound include heterogeneous thickening and loss of the endometrial-myometrial interface.
This document discusses invasive cervical cancer and the female genital system. It notes that invasive cervical cancer is most commonly epidermoid carcinoma, with risk factors being the same as for cervical intraepithelial neoplasia. The peak incidence is in the 4th to 6th decades of life. Grossly, cervical carcinoma arises from the squamocolumnar junction and can present as fungating, ulcerating or infiltrating. Distant metastases can occur in various organs. Histologically, epidermoid carcinoma is most common, and other patterns include adenocarcinoma and others. Clinical staging is done using the FIGO system. The document then discusses other topics related to the female genital system like dysfunctional uterine bleeding,
This MRI report describes findings for a 45-year-old woman with chronic pelvic pain. The MRI showed a bulky uterus with diffuse wall thickening up to 13 mm, consistent with adenomyosis. A well-defined cyst was also seen in the right adnexa. Adenomyosis is a common condition where endometrial tissue grows in the uterine wall and can cause symptoms like heavy periods. The MRI is helpful for diagnosing adenomyosis based on junctional zone thickening of 12 mm or more. In this case, the findings of diffuse uterine wall thickening and enhancement support a diagnosis of adenomyosis with an additional right adnexal cyst.
This document discusses endometriosis, defining it as the presence of endometrial tissue outside the uterus. It affects 7-10% of women. There are three main theories for its pathogenesis: retrograde menstruation, lymphatic/vascular dissemination, and coelomic metaplasia. Symptoms include dysmenorrhea, deep dyspareunia, and chronic pelvic pain. Endometriosis is most commonly found on the ovaries and other pelvic structures. Diagnosis requires laparoscopy and biopsy. Treatment options include medical therapy using hormones or NSAIDs as well as extirpative surgery to remove lesions.
Presentation1.pptx, radiological imaging of endometriosis.Abdellah Nazeer
Radiological imaging of endometriosis and adenomyosis.
Endometriosis and adenomyosis are common gynecological conditions that can be difficult to diagnose without imaging. MRI is the preferred imaging modality for evaluating these conditions. [1] Adenomyosis is characterized by ectopic endometrial glands within the myometrium, seen on MRI as junctional zone thickening over 12mm or ill-defined high T2 signal regions. [2] Endometriosis appears as powder-burn lesions, ovarian endometriomas or deep infiltrating nodules. Radiologists use MRI features like junctional zone measurements and high T1/T2 signals to diagnose and characterize
Transvaginal ultrasound and MRI are used to diagnose adenomyosis. On transvaginal ultrasound, the uterus may appear globally enlarged with heterogeneous myometrial texture and poorly defined endometrial-myometrial junction. MRI can identify adenomyosis as increased junctional zone thickness over 12mm with T2 hyperintense foci. Hysteroscopy with biopsy can confirm the diagnosis but is rarely used. Treatment options include NSAIDs, hormonal therapy like combined oral contraceptives or progestogens to reduce bleeding and pain, and long-acting reversible contraceptives like the levonorgestrel IUS.
Endometriosis is a condition where endometrial tissue grows outside the uterine cavity, most commonly on the ovaries and pelvic peritoneum. It causes pelvic pain and infertility and is diagnosed through laparoscopy. Treatment involves medical therapy using hormones to suppress menstruation, surgical excision or ablation of lesions, or a combination. Symptoms range from mild to severe depending on location and extent of disease.
Gynaecology Thicknend Endometrium leceture 3 part 2.pptxRadiantree
Endometrial cancer is the most common gynecological cancer in the general population. It typically affects postmenopausal women around age 65. Obesity, diabetes, hormone therapy, and tamoxifen use can increase risk. Patients often present with abnormal uterine bleeding. Ultrasound is used initially, with endometrial thickness under 5mm having a low risk of cancer. Sonohysterography may be used if the etiology of thickening remains unclear after biopsy or ultrasound. Features of cancer on ultrasound include heterogeneous thickening and loss of the endometrial-myometrial interface.
This document discusses invasive cervical cancer and the female genital system. It notes that invasive cervical cancer is most commonly epidermoid carcinoma, with risk factors being the same as for cervical intraepithelial neoplasia. The peak incidence is in the 4th to 6th decades of life. Grossly, cervical carcinoma arises from the squamocolumnar junction and can present as fungating, ulcerating or infiltrating. Distant metastases can occur in various organs. Histologically, epidermoid carcinoma is most common, and other patterns include adenocarcinoma and others. Clinical staging is done using the FIGO system. The document then discusses other topics related to the female genital system like dysfunctional uterine bleeding,
This MRI report describes findings for a 45-year-old woman with chronic pelvic pain. The MRI showed a bulky uterus with diffuse wall thickening up to 13 mm, consistent with adenomyosis. A well-defined cyst was also seen in the right adnexa. Adenomyosis is a common condition where endometrial tissue grows in the uterine wall and can cause symptoms like heavy periods. The MRI is helpful for diagnosing adenomyosis based on junctional zone thickening of 12 mm or more. In this case, the findings of diffuse uterine wall thickening and enhancement support a diagnosis of adenomyosis with an additional right adnexal cyst.
Invasive cervical cancer is most commonly epidermoid (squamous cell) carcinoma, arising from the squamocolumnar junction. The risk factors are the same as for cervical intraepithelial neoplasia. Advanced disease spreads to nearby structures like the bladder, rectum, and lymph nodes. Distant metastases occur in organs like the lungs and liver. Histologically, squamous cell carcinoma is the most common type, followed by adenocarcinoma and other rare variants. Clinical staging uses the FIGO system to determine treatment and prognosis.
Endometriosis and adenomyosis are common gynecological conditions where endometrial tissue grows outside or inside the uterus respectively. Endometriosis occurs when endometrial tissue implants itself in areas like the ovaries or pelvic wall, causing pain and infertility. Adenomyosis involves the growth of endometrial tissue deep in the uterine wall. Both are estrogen-dependent and resolve after menopause. Treatment options include medication to induce amenorrhea and reduce symptoms, or surgery for severe cases or women who have completed childbearing. Hysterectomy provides the only cure for adenomyosis.
This document discusses adenomyosis, including its definition, pathogenesis, clinical presentation, diagnostic modalities, and treatment options. Adenomyosis is defined as the benign invasion of endometrial glands and stroma into the myometrium. It most commonly presents in women aged 30-45 with symptoms like dysmenorrhea, heavy menstrual bleeding, and dyspareunia. Diagnosis can be made using ultrasound, MRI, or biopsy. Treatment involves conservative management, medical therapy like progestins or GnRH agonists, or surgical options such as hysterectomy or uterine-sparing procedures.
This document discusses adenomyosis and its relationship to infertility. It begins with background information on adenomyosis, including definitions, prevalence, symptoms, and theories of etiology. It then covers methods of diagnosis, including ultrasound, MRI, and hysteroscopy. Key diagnostic criteria on imaging studies are outlined. The document explores the association between adenomyosis and infertility, proposed mechanisms by which adenomyosis may impact fertility, and effects on outcomes of IVF treatment. While age is a confounding factor, studies suggest adenomyosis alone can increase rates of miscarriage and lower success of IVF. The document examines potential effects on utero-tubal transport, endometrial receptivity, implantation, and macrophage density.
A rare case of rectus sheath endometriosis at caesarean section scarMishra Sunita
This case report describes a rare case of scar endometriosis of the rectus sheath in a 27-year old female with a history of 3 previous cesarean sections. She presented with cyclical pain over her cesarean scar that increased during her menstrual cycle. Examination revealed a tender mass over the scar site. After excision and histopathological examination, it was confirmed to be a case of scar endometriosis of the rectus sheath, with endometrial glands and stroma seen within the fibrocollagenous tissue of the sheath. Scar endometriosis is a rare entity that is usually a direct result of inoculation of endometrial tissue into the abdominal wall during
1. Endometriosis involves endometrial tissue growing outside the uterus, most commonly on the ovaries, fallopian tubes, and tissue lining the pelvis.
2. It affects 6-10% of women and is a common cause of pelvic pain and infertility. While progression can be slow, it is a chronic condition with no permanent cure.
3. Diagnosis is often delayed due to non-specific symptoms like pelvic pain and difficulty becoming pregnant. Laparoscopy with biopsy of suspicious lesions remains the gold standard for diagnosis but ultrasound and MRI may also help identify locations of endometrial growth.
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
Invited lecture by Dr Sujoy Dasgupta in the Ultrasound Workshop of the Annual National Conference of Indian Association of Gynaecological Endoscopists (IAGE) held on 15 March 2024 at the Taj Ganges, Varanasi
Cutaneous cesarean scar endometriosis is a rare type of endometriosis where endometrial tissue grows outside the uterus in the cesarean section scar. It occurs when endometrial cells are transplanted into the scar during cesarean section surgery. Patients experience cyclical pain with their menstrual cycle. Treatment involves complete surgical excision of the tissue with clear margins to prevent recurrence. Thorough cleaning of surgical sites during cesarean sections may help reduce the risk of developing this condition.
Dr Sujoy Dasgupta was invited to deliver a lecture at the Conference of IMA (Indian Medical Association), held at July 2019 in Kolkata. This session was sponsored by Meyer Organic.
(I) The document discusses various types of ovarian tumours including functional cysts, inflammatory cysts, and benign and malignant neoplastic tumours.
(II) Functional cysts include follicular cysts, corpus luteal cysts, and theca lutein cysts which are usually asymptomatic and resolve on their own. Inflammatory cysts include tubo-ovarian abscesses.
(III) Benign neoplastic tumours discussed are serous cystadenoma, mucinous cystadenoma, dermoid cyst, fibroma, thecoma, and Brenner's tumour. Malignant transformations are possible in some tumour types.
Uterine Fibroids (Leiomyomata): Investigations and Treatment Michelle Fynes
Uterine fibroids (UF) are the most common benign neoplastic threat to women's health, costing hundreds of billions of health care dollars worldwide. The objective of this presentation is to review risk factors, aetiology, classification and clinical presentation of Uterine fibroids.
This document discusses sonographic criteria for uterine curettage when endometrial neoplasia is suspected. Eight premenopausal and perimenopausal women underwent transvaginal ultrasounds and uterine curettage due to abnormal bleeding or discharge. Histopathology found hyperplasia in polycystic ovary syndrome patients and cancer in a patient on tamoxifen therapy. Key ultrasound findings associated with hyperplasia or cancer included thick irregular endometrium, ill-defined endometrial-myometrial junction, intrauterine fluid collections, adnexal masses, and cystic endometrial areas. The document concludes that endometrial stripe abnormalities on ultrasound, in addition to thickness, are important
This document provides information on carcinoma endometrium, including its introduction, predisposing factors, pathology, symptoms, investigations, differential diagnosis, screening, staging, treatment, survival rates, and sarcoma of the uterus. Some key points include:
1. Carcinoma endometrium accounts for 7% of cancers in women and peaks between ages 55-69. Over three-fourths are diagnosed when still localized.
2. Predisposing factors include unsupervised hormone therapy, hyperestrogenic states, familial factors, and tamoxifen use.
3. Investigations include ultrasounds, endometrial sampling, hysteroscopy, and biopsy. Staging involves assessing
Uterine sarcoma presentation (ibanda and ongala)hood ibanda
Uterine sarcoma refers to rare soft tissue tumors of the uterus that are of mesenchymal origin. While symptoms are vague, abnormal vaginal bleeding or pelvic pain in postmenopausal women should raise suspicion. Diagnosis relies on histopathology, as imaging cannot reliably differentiate sarcomas from fibroids. Treatment involves total abdominal hysterectomy with bilateral salpingo-oophorectomy for early-stage disease. Prognosis is generally poor due to high recurrence rates, with stage being the most important prognostic factor.
- An adnexal mass refers to a lump near the uterus, ovaries, fallopian tubes, or surrounding tissue. Imaging can help determine if a mass is benign or cancerous.
- Common benign adnexal masses include physiologic cysts, peritoneal inclusion cysts, and masses related to conditions like ovarian hyperstimulation syndrome or polycystic ovary syndrome. Masses may also be due to endometriosis.
- Potentially cancerous masses include various epithelial tumors of the ovaries, such as serous or mucinous tumors. Other ovarian cancers include clear cell carcinoma and germ cell tumors. Imaging can help identify features suggesting malignancy.
This document provides an overview of common gynecological conditions that can be imaged. It describes bicornuate uterus, uterine fibroids, pedunculated fibroids, adenomyosis, endometriosis, endometrial hyperplasia, endometrial carcinoma, cervical carcinoma, hemorrhagic cyst, benign and malignant cystic ovarian neoplasms, dermoid cysts, ovarian hyperstimulation syndrome, and polycystic ovarian syndrome. For each condition, it discusses appearance on ultrasound and MRI as well as key diagnostic features.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Invasive cervical cancer is most commonly epidermoid (squamous cell) carcinoma, arising from the squamocolumnar junction. The risk factors are the same as for cervical intraepithelial neoplasia. Advanced disease spreads to nearby structures like the bladder, rectum, and lymph nodes. Distant metastases occur in organs like the lungs and liver. Histologically, squamous cell carcinoma is the most common type, followed by adenocarcinoma and other rare variants. Clinical staging uses the FIGO system to determine treatment and prognosis.
Endometriosis and adenomyosis are common gynecological conditions where endometrial tissue grows outside or inside the uterus respectively. Endometriosis occurs when endometrial tissue implants itself in areas like the ovaries or pelvic wall, causing pain and infertility. Adenomyosis involves the growth of endometrial tissue deep in the uterine wall. Both are estrogen-dependent and resolve after menopause. Treatment options include medication to induce amenorrhea and reduce symptoms, or surgery for severe cases or women who have completed childbearing. Hysterectomy provides the only cure for adenomyosis.
This document discusses adenomyosis, including its definition, pathogenesis, clinical presentation, diagnostic modalities, and treatment options. Adenomyosis is defined as the benign invasion of endometrial glands and stroma into the myometrium. It most commonly presents in women aged 30-45 with symptoms like dysmenorrhea, heavy menstrual bleeding, and dyspareunia. Diagnosis can be made using ultrasound, MRI, or biopsy. Treatment involves conservative management, medical therapy like progestins or GnRH agonists, or surgical options such as hysterectomy or uterine-sparing procedures.
This document discusses adenomyosis and its relationship to infertility. It begins with background information on adenomyosis, including definitions, prevalence, symptoms, and theories of etiology. It then covers methods of diagnosis, including ultrasound, MRI, and hysteroscopy. Key diagnostic criteria on imaging studies are outlined. The document explores the association between adenomyosis and infertility, proposed mechanisms by which adenomyosis may impact fertility, and effects on outcomes of IVF treatment. While age is a confounding factor, studies suggest adenomyosis alone can increase rates of miscarriage and lower success of IVF. The document examines potential effects on utero-tubal transport, endometrial receptivity, implantation, and macrophage density.
A rare case of rectus sheath endometriosis at caesarean section scarMishra Sunita
This case report describes a rare case of scar endometriosis of the rectus sheath in a 27-year old female with a history of 3 previous cesarean sections. She presented with cyclical pain over her cesarean scar that increased during her menstrual cycle. Examination revealed a tender mass over the scar site. After excision and histopathological examination, it was confirmed to be a case of scar endometriosis of the rectus sheath, with endometrial glands and stroma seen within the fibrocollagenous tissue of the sheath. Scar endometriosis is a rare entity that is usually a direct result of inoculation of endometrial tissue into the abdominal wall during
1. Endometriosis involves endometrial tissue growing outside the uterus, most commonly on the ovaries, fallopian tubes, and tissue lining the pelvis.
2. It affects 6-10% of women and is a common cause of pelvic pain and infertility. While progression can be slow, it is a chronic condition with no permanent cure.
3. Diagnosis is often delayed due to non-specific symptoms like pelvic pain and difficulty becoming pregnant. Laparoscopy with biopsy of suspicious lesions remains the gold standard for diagnosis but ultrasound and MRI may also help identify locations of endometrial growth.
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
Invited lecture by Dr Sujoy Dasgupta in the Ultrasound Workshop of the Annual National Conference of Indian Association of Gynaecological Endoscopists (IAGE) held on 15 March 2024 at the Taj Ganges, Varanasi
Cutaneous cesarean scar endometriosis is a rare type of endometriosis where endometrial tissue grows outside the uterus in the cesarean section scar. It occurs when endometrial cells are transplanted into the scar during cesarean section surgery. Patients experience cyclical pain with their menstrual cycle. Treatment involves complete surgical excision of the tissue with clear margins to prevent recurrence. Thorough cleaning of surgical sites during cesarean sections may help reduce the risk of developing this condition.
Dr Sujoy Dasgupta was invited to deliver a lecture at the Conference of IMA (Indian Medical Association), held at July 2019 in Kolkata. This session was sponsored by Meyer Organic.
(I) The document discusses various types of ovarian tumours including functional cysts, inflammatory cysts, and benign and malignant neoplastic tumours.
(II) Functional cysts include follicular cysts, corpus luteal cysts, and theca lutein cysts which are usually asymptomatic and resolve on their own. Inflammatory cysts include tubo-ovarian abscesses.
(III) Benign neoplastic tumours discussed are serous cystadenoma, mucinous cystadenoma, dermoid cyst, fibroma, thecoma, and Brenner's tumour. Malignant transformations are possible in some tumour types.
Uterine Fibroids (Leiomyomata): Investigations and Treatment Michelle Fynes
Uterine fibroids (UF) are the most common benign neoplastic threat to women's health, costing hundreds of billions of health care dollars worldwide. The objective of this presentation is to review risk factors, aetiology, classification and clinical presentation of Uterine fibroids.
This document discusses sonographic criteria for uterine curettage when endometrial neoplasia is suspected. Eight premenopausal and perimenopausal women underwent transvaginal ultrasounds and uterine curettage due to abnormal bleeding or discharge. Histopathology found hyperplasia in polycystic ovary syndrome patients and cancer in a patient on tamoxifen therapy. Key ultrasound findings associated with hyperplasia or cancer included thick irregular endometrium, ill-defined endometrial-myometrial junction, intrauterine fluid collections, adnexal masses, and cystic endometrial areas. The document concludes that endometrial stripe abnormalities on ultrasound, in addition to thickness, are important
This document provides information on carcinoma endometrium, including its introduction, predisposing factors, pathology, symptoms, investigations, differential diagnosis, screening, staging, treatment, survival rates, and sarcoma of the uterus. Some key points include:
1. Carcinoma endometrium accounts for 7% of cancers in women and peaks between ages 55-69. Over three-fourths are diagnosed when still localized.
2. Predisposing factors include unsupervised hormone therapy, hyperestrogenic states, familial factors, and tamoxifen use.
3. Investigations include ultrasounds, endometrial sampling, hysteroscopy, and biopsy. Staging involves assessing
Uterine sarcoma presentation (ibanda and ongala)hood ibanda
Uterine sarcoma refers to rare soft tissue tumors of the uterus that are of mesenchymal origin. While symptoms are vague, abnormal vaginal bleeding or pelvic pain in postmenopausal women should raise suspicion. Diagnosis relies on histopathology, as imaging cannot reliably differentiate sarcomas from fibroids. Treatment involves total abdominal hysterectomy with bilateral salpingo-oophorectomy for early-stage disease. Prognosis is generally poor due to high recurrence rates, with stage being the most important prognostic factor.
- An adnexal mass refers to a lump near the uterus, ovaries, fallopian tubes, or surrounding tissue. Imaging can help determine if a mass is benign or cancerous.
- Common benign adnexal masses include physiologic cysts, peritoneal inclusion cysts, and masses related to conditions like ovarian hyperstimulation syndrome or polycystic ovary syndrome. Masses may also be due to endometriosis.
- Potentially cancerous masses include various epithelial tumors of the ovaries, such as serous or mucinous tumors. Other ovarian cancers include clear cell carcinoma and germ cell tumors. Imaging can help identify features suggesting malignancy.
This document provides an overview of common gynecological conditions that can be imaged. It describes bicornuate uterus, uterine fibroids, pedunculated fibroids, adenomyosis, endometriosis, endometrial hyperplasia, endometrial carcinoma, cervical carcinoma, hemorrhagic cyst, benign and malignant cystic ovarian neoplasms, dermoid cysts, ovarian hyperstimulation syndrome, and polycystic ovarian syndrome. For each condition, it discusses appearance on ultrasound and MRI as well as key diagnostic features.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Nutritional deficiency Disorder are problems in india.
It is very important to learn about Indian child's nutritional parameters as well the Disease related to alteration in their Nutrition.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
The Children are very vulnerable to get affected with respiratory disease.
In our country, the respiratory Disease conditions are consider as major cause for mortality and Morbidity in Child.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Diagnosing adenomyosis .pptx
1. Diagnosing Adenomyosis
Dr. Chandana Jayasundara
MBBS, MD, MRCOG (UK)
Senior Lecturer in Obstetrics and Gynaecology
Faculty of Medicine,
University of Colombo
Honorary Consultant Obstetrician and Gynaecologist
DSHW and NHSL
2. Introduction
• ADENOMYOSIS………….
• Dr Rokitanski was the first to describe the existence of ectopic
endometrium in the uterine musculature in 1860 and named it
“Adenomyoma”
• Von Reklinghausen in 1896 described the diffuse involvement
myometrium as Adenomyosis
• In 1925, Frankl formaly introduced the term Adenomyosis
3. Adenomyosis: Prevalence
• Studies have reported a wide range (9-62%) in women undergoing
hysterectomy
• Diagnosing Adenomyosis by ultrasound has revolutionized the
detection of Adenomyosis
• These studies suggest Adenomyosis to occur at younger ages with a
prevalence of 20-35% (Pinsauti S et al)
• The mean age of 26 years has been quoted in one study (Naftalin J et
al)
4. Pathogenesis
• Four theories
• Endomyometrial invagination of the endometrium
• De novo from the Mullarian remnants
• Microtrauma of the endometrial/myometrial interface (Junctional zone [JZ])
• Establishment of lesions from retrograde menstruation
5. Lack of basement membrane between endometrium and myometrium and
damage to the JZ will influence the process
This explain ultrasound findings of subendometrial lines and buds with expansion
to hyperechogenic islands in the myometrium
6. Pathogenesis -
• Infiltration of endometriosis from outside the uterus, with disruption
of the serosa and infiltration of the external myometrium inducing
another subtype of Adenomyosis (Kishi et al)
7. Histopathological diagnosis of adenomyosis
• Disruption of the normal boundary between the endometrium and
myometrium
• Presence of ectopic endometrium that is basal-type non-secretory
tissue with a direct connection to the basalis layer
• Myometrial invasion by endometrium > 4 mm below the basalis layer
• Myometrial invasion by endometrium > 2.5 mm below the basalis
layer
• Endometrial invasion to > 25% of the thickness of the uterine
musculature, as measured from the endometrial–myometrial junction
8. Histological diagnosis cont……
• Different classifications have been suggested depending on
histological disease severity , but without international consensus
1. Focal Adenomyosis :-circumscribed nodular aggregates of endometrial
glands and stroma surrounded by normal myometrium
2. Diffuse Adenomyosis:- presence of endometrial glands and stroma
distributed diffusely throughout the myometrium
3. Adenomyoma:-a subgroup of focal adenomyosis surrounded by
hypertrophic myometrium
9. Diagnosing Adenomyosis
• Clinical presentation
• Dysmenorrhoea
• Abnormal uterine bleeding
(Heavy)
• Pelvic pain
• Dysphareunia
• Reduced fertility
• Asymptomatic
• History
• Age
• Age at menarche
• Gravidity and parity
• Clinical presentation of symp/signs
• Effect on quality of life
10. Examination
• Bimanual examination of the pelvis can help physicians to gauge the
uterine size and mobility, and adnexal masses
• Assessment of pelvic pain, and, if so, type, severity, and localization of
pain, to raise or rule out the possibility of the presence of deep
endometriosis in the retrocervical region.
11. Non invasive imaging for the diagnosis of
Adenomyosis
• Magnetic resonance imaging (MRI) and ultrasound have gradually
become the mainstay for the diagnosis of Adenomyosis.
• Trans-vaginal ultrasound (TVUS) is the first‐line technique in
gynecological work‐up (Tellum et al, 2019; Liu et al., 2021; Chapron et al., 2020; Bazot et al.,
2018)
• Through two‐dimensional (2D) and 3D settings and color flow Doppler
versions of TVUS, a good view of the uterus and its pathology can be obtained
• Compared with TVUS, trans-abdominal ultrasonography has limited value.
• Compared with 2D and 3D TVUS, color flow Doppler ultrasonography has the
added advantage of providing information on the location, amount, and type
of blood flow.
• MRI should be used as second line in diagnosing Adenomyosis
12. Morphological Uterus Sonographic Assessment
(MUSA) consensus
• This guidance was published by an international expert panel in 2015.
Van den Bosch, Dueholm et al., Ultrasound Obstet Gynecol 2015
• It describes both the features for diagnosing adenomyosis as well as
guidance on reporting adenomyosis ultrasonically
13. The MUSA consensus on diagnosing
Adenomyosis with TVUS
• Measure asymmetry, look for the globular shape
• Evaluate myometrial architecture
• Intramyometrial cysts
• Echogenic subendometrial lines and buds
• Hyperechoic islands
• Fan-shaped shadowing
• Translesional vascularity
• Study the junctional zone with 3D TVUS junctional Zones
• Thickness, Disruption, irregularity and difference between minimum &
maximum thickness etc
20. MUSA guidance on reporting Adenomyosis
• Seven items should be assessed when examining and describing a
uterus with Adenomyosis
Presence Classify as normal or abnormal and if abnormal whether it is Adenomyosis, myoma or sarcoma.
Use MUSA diagnosing criteria to identify adenomyosis
location Describe the location:- Anterior, Posterior, Right lateral, Left lateral, Fundal.
21. Distribution Focal 25% or more of the lesion is surrounded by normal endometrium. When focal
adenomyosis is formed by invasion from outside to inside, it is referred to as
Focal Adenomyosis of the Outer Myometrium (FOAM)
Adenomyoma Lesion is demarcated distinctly and is totally surrounded by hypertrophic
myometrium
Diffuse Present throughout myometrium
Mixed Both the focal and diffuse disease present
Presence of Cysts Cystic/non-cystic Presence or absence of intra-myometrial cysts measuring 2 mm or more
22. Layer of uterine
involvement
Type 1 Involvement of the junctional zone
Type 2 Involvement of the middle myometrium
Type 3 Involvement of the outer myometrium. Demarcation between middle and
outer myometrium is determined by using colour Doppler to delineate
the vascular arcade
Multiple layers Involvement of more than one layer (1-2, 1-3)
Extent Mild <25% affected
moderate 25-50% affected
severe >50% affected
Lesion size Lesion/s is/are measured in their longest diameter/s
23.
24. Guidance of Asian Society of endometriosis
recommendation Level of
recommendation
Grade of
recommendation
Transvaginal ultrasound (TVUS) and Magnetic Resonance Imaging (MRI)
are good noninvasive methods of diagnosing adenomyosis.
1a A
TVUS should be considered the first‐line diagnostic method while MRI is
recommended as a second‐line method when TVUS is inconclusive.
1a A
Most diagnostic features of adenomyosis could be demonstrated using
two‐dimensional (2D) TVUS and the addition of three‐dimensional (3D)
TVUS will not increase the diagnostic accuracy significantly.
1a A
25. Transabdominal ultrasound is of limited value but may be of use when
TVUS is not possible or with grossly enlarged uteri. The method has a low
specificity (30%) compared to TVUS (up to 100%).
4 C